Logo image of TRMK

TRUSTMARK CORP (TRMK) Stock Fundamental Analysis

NASDAQ:TRMK - Nasdaq - US8984021027 - Common Stock - Currency: USD

38.13  +0.63 (+1.68%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to TRMK. TRMK was compared to 395 industry peers in the Banks industry. TRMK has a medium profitability rating, but doesn't score so well on its financial health evaluation. TRMK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

TRMK had positive earnings in the past year.
In the past year TRMK had a positive cash flow from operations.
Each year in the past 5 years TRMK has been profitable.
TRMK had a positive operating cash flow in each of the past 5 years.
TRMK Yearly Net Income VS EBIT VS OCF VS FCFTRMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of TRMK (1.29%) is better than 82.53% of its industry peers.
With an excellent Return On Equity value of 11.63%, TRMK belongs to the best of the industry, outperforming 81.01% of the companies in the same industry.
Industry RankSector Rank
ROA 1.29%
ROE 11.63%
ROIC N/A
ROA(3y)0.84%
ROA(5y)0.86%
ROE(3y)8.71%
ROE(5y)8.76%
ROIC(3y)N/A
ROIC(5y)N/A
TRMK Yearly ROA, ROE, ROICTRMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With an excellent Profit Margin value of 41.10%, TRMK belongs to the best of the industry, outperforming 96.71% of the companies in the same industry.
TRMK's Profit Margin has improved in the last couple of years.
TRMK does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 41.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.81%
PM growth 5Y10.6%
GM growth 3YN/A
GM growth 5YN/A
TRMK Yearly Profit, Operating, Gross MarginsTRMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

TRMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
TRMK has about the same amout of shares outstanding than it did 1 year ago.
TRMK has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, TRMK has an improved debt to assets ratio.
TRMK Yearly Shares OutstandingTRMK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TRMK Yearly Total Debt VS Total AssetsTRMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

TRMK has a debt to FCF ratio of 4.09. This is a neutral value as TRMK would need 4.09 years to pay back of all of its debts.
TRMK has a Debt to FCF ratio of 4.09. This is in the lower half of the industry: TRMK underperforms 67.34% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that TRMK is not too dependend on debt financing.
TRMK has a worse Debt to Equity ratio (0.47) than 77.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.09
Altman-Z N/A
ROIC/WACCN/A
WACC17.22%
TRMK Yearly LT Debt VS Equity VS FCFTRMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
TRMK Yearly Current Assets VS Current LiabilitesTRMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.79% over the past year.
TRMK shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.95% yearly.
Looking at the last year, TRMK shows a very negative growth in Revenue. The Revenue has decreased by -22.46% in the last year.
TRMK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.19% yearly.
EPS 1Y (TTM)28.79%
EPS 3Y9.95%
EPS 5Y5.95%
EPS Q2Q%29.41%
Revenue 1Y (TTM)-22.46%
Revenue growth 3Y-4.97%
Revenue growth 5Y-2.19%
Sales Q2Q%3.02%

3.2 Future

TRMK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.58% yearly.
The Revenue is expected to grow by 4.80% on average over the next years.
EPS Next Y14.03%
EPS Next 2Y8.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.65%
Revenue Next 2Y4.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TRMK Yearly Revenue VS EstimatesTRMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
TRMK Yearly EPS VS EstimatesTRMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.52, the valuation of TRMK can be described as reasonable.
Based on the Price/Earnings ratio, TRMK is valued a bit cheaper than the industry average as 67.34% of the companies are valued more expensively.
TRMK is valuated cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.40 indicates a reasonable valuation of TRMK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TRMK is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.70. TRMK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.52
Fwd PE 10.4
TRMK Price Earnings VS Forward Price EarningsTRMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of TRMK indicates a somewhat cheap valuation: TRMK is cheaper than 64.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.94
EV/EBITDA N/A
TRMK Per share dataTRMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.82
PEG (5Y)1.94
EPS Next 2Y8.58%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

TRMK has a Yearly Dividend Yield of 2.64%.
TRMK's Dividend Yield is comparable with the industry average which is at 3.47.
TRMK's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.64%

5.2 History

The dividend of TRMK has a limited annual growth rate of 0.23%.
TRMK has paid a dividend for at least 10 years, which is a reliable track record.
TRMK has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.23%
Div Incr Years0
Div Non Decr Years34
TRMK Yearly Dividends per shareTRMK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

TRMK pays out 24.38% of its income as dividend. This is a sustainable payout ratio.
TRMK's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.38%
EPS Next 2Y8.58%
EPS Next 3YN/A
TRMK Yearly Income VS Free CF VS DividendTRMK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
TRMK Dividend Payout.TRMK Dividend Payout, showing the Payout Ratio.TRMK Dividend Payout.PayoutRetained Earnings

More info and screens

TRUSTMARK CORP

NASDAQ:TRMK (7/2/2025, 3:56:09 PM)

38.13

+0.63 (+1.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners74.92%
Inst Owner Change1.71%
Ins Owners1.71%
Ins Owner Change6.6%
Market Cap2.31B
Analysts76.67
Price Target42.33 (11.01%)
Short Float %3.32%
Short Ratio5.94
Dividend
Industry RankSector Rank
Dividend Yield 2.64%
Yearly Dividend0.93
Dividend Growth(5Y)0.23%
DP24.38%
Div Incr Years0
Div Non Decr Years34
Ex-Date05-30 2025-05-30 (0.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.31%
Min EPS beat(2)5.43%
Max EPS beat(2)9.2%
EPS beat(4)4
Avg EPS beat(4)5.09%
Min EPS beat(4)0.64%
Max EPS beat(4)9.2%
EPS beat(8)7
Avg EPS beat(8)4.51%
EPS beat(12)10
Avg EPS beat(12)-9.69%
EPS beat(16)12
Avg EPS beat(16)-8.36%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)1.08%
Revenue beat(4)1
Avg Revenue beat(4)-8.53%
Min Revenue beat(4)-33.86%
Max Revenue beat(4)1.08%
Revenue beat(8)2
Avg Revenue beat(8)-3.99%
Revenue beat(12)4
Avg Revenue beat(12)-2.74%
Revenue beat(16)5
Avg Revenue beat(16)-2.63%
PT rev (1m)0.12%
PT rev (3m)-3.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.77%
EPS NY rev (1m)0%
EPS NY rev (3m)3.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 11.52
Fwd PE 10.4
P/S 4.03
P/FCF 9.94
P/OCF 8.94
P/B 1.14
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)3.31
EY8.68%
EPS(NY)3.67
Fwd EY9.62%
FCF(TTM)3.84
FCFY10.07%
OCF(TTM)4.26
OCFY11.18%
SpS9.46
BVpS33.42
TBVpS25.67
PEG (NY)0.82
PEG (5Y)1.94
Profitability
Industry RankSector Rank
ROA 1.29%
ROE 11.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 41.1%
GM N/A
FCFM 40.58%
ROA(3y)0.84%
ROA(5y)0.86%
ROE(3y)8.71%
ROE(5y)8.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.81%
PM growth 5Y10.6%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.09
Debt/EBITDA N/A
Cap/Depr 67.69%
Cap/Sales 4.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 98.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC17.22%
ROIC/WACCN/A
Cap/Depr(3y)98.8%
Cap/Depr(5y)87.82%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.28%
Profit Quality(3y)164.76%
Profit Quality(5y)146.26%
High Growth Momentum
Growth
EPS 1Y (TTM)28.79%
EPS 3Y9.95%
EPS 5Y5.95%
EPS Q2Q%29.41%
EPS Next Y14.03%
EPS Next 2Y8.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.46%
Revenue growth 3Y-4.97%
Revenue growth 5Y-2.19%
Sales Q2Q%3.02%
Revenue Next Year5.65%
Revenue Next 2Y4.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.4%
FCF growth 3Y-34.72%
FCF growth 5Y0.61%
OCF growth 1Y8.72%
OCF growth 3Y-30.53%
OCF growth 5Y0.09%